| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5887609 | Seminars in Arthritis and Rheumatism | 2015 | 7 Pages |
Abstract
Safety considerations in the development of biosimilars are an important focus of regulatory guidelines, although topics such as interchangeability, automatic substitution, and nomenclature are still being debated.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Walter MD, Josef MD,